Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mini Salud PublfiledCriticalMini Salud Publ
Priority to CU36161ApriorityCriticalpatent/CU21827A1/en
Publication of CU21827A1publicationCriticalpatent/CU21827A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
El producto está compuesto por yodo de 0.65 a 0.95%, mercuribromofluoresceína de 0.65 a 0.85%, sulfatiazol de 0.50 a 0.75%, produciendo una rápida cicatrización de las áreas afectadas.The product is made up of iodine from 0.65 to 0.95%, mercuribromofluorescein from 0.65 to 0.85%, sulfathiazole from 0.50 to 0.75%, producing rapid healing of the affected areas.